CH451407A - Procédé de préparation de vaccins antigènes somatiques - Google Patents

Procédé de préparation de vaccins antigènes somatiques

Info

Publication number
CH451407A
CH451407A CH1271465A CH1271465A CH451407A CH 451407 A CH451407 A CH 451407A CH 1271465 A CH1271465 A CH 1271465A CH 1271465 A CH1271465 A CH 1271465A CH 451407 A CH451407 A CH 451407A
Authority
CH
Switzerland
Prior art keywords
bacteria
strains
glycine
vaccine
vaccines
Prior art date
Application number
CH1271465A
Other languages
English (en)
French (fr)
Inventor
Greenberg Louis
Yvonne Cooper Margaret
Original Assignee
Canadian Patents Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents Dev filed Critical Canadian Patents Dev
Publication of CH451407A publication Critical patent/CH451407A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH1271465A 1964-09-14 1965-09-14 Procédé de préparation de vaccins antigènes somatiques CH451407A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39637364A 1964-09-14 1964-09-14
US42013064A 1964-12-21 1964-12-21

Publications (1)

Publication Number Publication Date
CH451407A true CH451407A (fr) 1968-05-15

Family

ID=27015479

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1271465A CH451407A (fr) 1964-09-14 1965-09-14 Procédé de préparation de vaccins antigènes somatiques

Country Status (11)

Country Link
JP (1) JPS4918206B1 (xx)
AT (1) AT285044B (xx)
BE (1) BE669561A (xx)
CH (1) CH451407A (xx)
DE (1) DE1467849A1 (xx)
DK (1) DK113866B (xx)
ES (1) ES317455A1 (xx)
FR (1) FR5488M (xx)
GB (1) GB1100190A (xx)
NL (1) NL6511898A (xx)
SE (1) SE335780B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2088112B2 (xx) * 1970-05-20 1975-01-10 Cassenne Lab Sa
NZ553776A (en) * 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
AU2011265368B9 (en) * 2004-09-22 2012-11-29 Biosynexus Incorporated Immunogenic composition
CN111254103B (zh) * 2019-11-19 2023-06-02 河南省生物工程技术研究中心 一种非洲猪瘟基因工程疫苗高密度发酵补料培养基及发酵工艺

Also Published As

Publication number Publication date
SE335780B (xx) 1971-06-07
AT285044B (de) 1970-10-12
JPS4918206B1 (xx) 1974-05-08
DK113866B (da) 1969-05-05
DE1467849A1 (de) 1968-11-28
GB1100190A (en) 1968-01-24
NL6511898A (xx) 1966-03-15
ES317455A1 (es) 1966-04-01
BE669561A (xx) 1965-12-31
FR5488M (xx) 1967-10-30

Similar Documents

Publication Publication Date Title
Jenkin et al. In vitro studies on the interaction between mouse peritoneal macrophages and strains of Salmonella and Escherichia coli
Harro et al. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration
JP5249326B2 (ja) 不活化ブドウ球菌全細胞ワクチン
EP0172212A1 (en) Biological preparations and their use
EP0560968B1 (fr) Vaccin contre les infections a neisseria meningitidis
JPH06501478A (ja) ブドウ膜炎の処置
CN102238960B (zh) 制造疫苗的方法
Kudyar et al. Periodontal vaccine: A dream or reality
CZ202394A3 (en) Use of antigenic and/or immunoregulating material derived from mycobacterium vaccae when preparing a therapeutic substance containing such material and a pharmaceutical substance containing this material
US3532790A (en) Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
FR2481928A1 (fr) Nouveaux mutants bacteriens, procede de leur production et vaccins vivants les contenant
WO2001019395A1 (fr) Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
TW403655B (en) Novel attenuated pseudomonas aeruginosa strains
CH451407A (fr) Procédé de préparation de vaccins antigènes somatiques
EP1095662B1 (fr) Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
EP0051522B1 (fr) Mutant de septicémie hémorragique virale, vaccin contenant ce mutant et procédé pour sa préparation
Ørskov et al. Studies on the significance of “Vi Antigen” in the Mechanism of Typhoid Infection in Mice
JP2005519941A (ja) 結核の管理のために有用な医薬組成物の製造方法
CN1210062C (zh) 猪红斑丹毒丝菌抗原及其疫苗组合物
EP0088302B1 (fr) Neurotoxine de E.coli détoxifiée, procédé pour la préparer et compositions immunologiques la contenant
RU2190424C1 (ru) Антигенный состав чумной химической вакцины
RU2098128C1 (ru) Ассоциированная вакцина "овикон" против инфекционных заболеваний конечностей овец
EP1628683B1 (fr) Composition vaccinale comprenant du phosphate de fer a titre d' adjuvant vaccinal
Pollitzer Plague studies: 2. The plague bacillus
FR2652266A1 (fr) Vaccin protecteur contre l'hemophilose porcine.